Cargando…

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus

Epstein-Barr virus (EBV) is tightly associated with certain human cancers, but there is as yet no specific treatment against EBV-related diseases. The EBV-encoded EBNA1 protein is essential to maintain viral episomes and for viral persistence. As such, EBNA1 is expressed in all EBV-infected cells, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voisset, Cécile, Daskalogianni, Chrysoula, Contesse, Marie-Astrid, Mazars, Anne, Arbach, Hratch, Le Cann, Marie, Soubigou, Flavie, Apcher, Sébastien, Fåhraeus, Robin, Blondel, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974454/ https://www.ncbi.nlm.nih.gov/pubmed/24558096 http://dx.doi.org/10.1242/dmm.014308

Ejemplares similares

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness
por: Lista, María José, et al.
Publicado: (2017)

Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA
por: Lista, María José, et al.
Publicado: (2017)

Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
por: Apcher, Sebastien, et al.
Publicado: (2010)

Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation
por: Blondel, Marc, et al.
Publicado: (2016)

Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion
por: Angrand, Gaëlle, et al.
Publicado: (2019)

Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides
por: Martins, Rodrigo Prado, et al.
Publicado: (2019)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
por: Wilson, Joanna B., et al.
Publicado: (2018)

In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules
por: Prado Martins, Rodrigo, et al.
Publicado: (2018)

Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway
por: Duvallet, Emilie, et al.
Publicado: (2016)

Association of the Epstein-Barr virus with breast cancer: in vivo and in vitro studies
por: Bonnet-Duqeynoy, M, et al.
Publicado: (2001)

The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA
por: Zheng, Alice J L, et al.
Publicado: (2022)

An update: Epstein-Barr virus and immune evasion via microRNA regulation
por: Zuo, Lielian, et al.
Publicado: (2017)

Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system
por: Angrand, Gaelle, et al.
Publicado: (2022)

Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance
por: Sroka, Ewa Maria, et al.
Publicado: (2023)

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
por: van Gent, Michiel, et al.
Publicado: (2014)

Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta
por: Almohammed, Rajaei, et al.
Publicado: (2018)

Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8(+) T cell immunity
por: Rowe, Martin, et al.
Publicado: (2010)

PI3Kδ activates E2F1 synthesis in response to mRNA translation stress
por: Gnanasundram, Sivakumar Vadivel, et al.
Publicado: (2017)

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
por: Gram, Anna M., et al.
Publicado: (2016)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2023)

Epstein–Barr virus-associated nephrotic syndrome
por: Mikhalkova, Deana, et al.
Publicado: (2012)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

The different activities of RNA G-quadruplex structures are controlled by flanking sequences
por: Zheng, Alice J-L, et al.
Publicado: (2021)

No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue
por: Wilms, Torben, et al.
Publicado: (2017)

MDM2’s dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities
por: Gnanasundram, Sivakumar Vadivel, et al.
Publicado: (2020)

Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function
por: Campbell, Ashley M., et al.
Publicado: (2022)

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
por: Zuo, Jianmin, et al.
Publicado: (2009)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

p53, p63 and p73 in the wonderland of S. cerevisiae
por: Billant, Olivier, et al.
Publicado: (2017)

A CD8(+) T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
por: Hislop, Andrew D., et al.
Publicado: (2007)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_kdvs1tnj4dd079rats583d1f6v